Operating
Asset write-downs
Edwards Lifesciences Asset write-downs increased by 162.4% to $123.60M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2020
Last reportedQ1 2026May 6, 2026
How to read this metric
High impairment charges suggest poor past investment decisions or deteriorating market conditions for specific business units.
Detailed definition
These are non-cash charges recognized when the carrying value of an asset exceeds its fair market value. They indicate t...
Peer comparison
Common in insurance and financial services during economic downturns; peers will report these when asset valuations decline.
Metric ID:
operating_asset_impairment_chargesHistorical Data
12 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q4 '23 | Q2 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $1.00M | $1.00M | $13.78M | $13.78M | $13.78M | $13.78M | $0.00 | $0.00 | $0.00 | $47.10M | $123.60M |
| QoQ Change | — | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | -100.0% | — | — | — | +162.4% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | -100.0% | — | — | — | — |
Range$0.00 – $123.60M
CAGR+476.4%
Avg YoY Growth+933.1%
Median YoY Growth>999%
Asset write-downs at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's asset write-downs?
- Edwards Lifesciences (EW) reported asset write-downs of $123.60M in Q1 2026.
- What does asset write-downs mean?
- A write-down in the value of assets that are no longer worth as much as previously recorded.